A Study of LY2880070 in Participants With Advanced or Metastatic Cancer

Clinical trial NCT02632448 · COMPLETED

Trial details

NCT number: NCT02632448
Sponsor: Esperas Pharma Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumors Colorectal Cancer Breast Cancer Ovarian Cancer Colon Cancer Rectal Cancer Neoplasms Endometrial Cancer Soft Tissue Sarcoma Triple Negative Breast Cancer Pancreas Cancer Pancreatic Cancer

Start date: 2016-05-16
Primary completion: 2025-04-14
Enrollment: 229

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.